Mandatory Newborn Screening May Cut Deaths Due to Rare Diseases
The QuintAccording to the health advocacy groups fighting for the cause of rare diseases in India, the medicines to treat such diseases range anywhere between Rs 1 lakh to Rs 50 lakh per month. In 2017, the National Policy for Treatment of Rare Diseases was announced by the Indian government with a corpus of Rs 100 crore to provide financial assistance for the treatment of rare disease patients. National bodies working for the well being of patients with rare diseases have urged the government for setting up genetic screening laboratories in every government hospitals so that newborns can be screened if they have any life threatening genetic disorder. At present, only a few top government hospitals such as the All India Institute of Medical Sciences and Post Graduate Institute of Medical Education and Research, Chandigarh apart from the private hospitals have the newborn screening tests, making it extremely costly and unaffordable for the people from low-income group, a strata from where genetic disorder cases are frequent.